Validation of a Contactless Vital Signs Measurement Sensor

  • End date
    Dec 31, 2021
  • participants needed
  • sponsor
    Sleepiz AG
Updated on 21 March 2021


The primary aim of this study is to validate the performance of Sleepiz One+ for the measurement of vital physiological parameters in adult population, against a laboratory-based polysomnography. Additionally, the investigators will evaluate Sleepiz One+ ability to identify patients with a high risk of suffering from a sleep-related breathing disorder based on apnea-hypopnea index estimation. Participants will undergo measurement with Sleepiz One+ and a polysomnography device while resting in bed for 20 min as well as during sleep for the duration of the following night.

Condition Sleep apnea, Sleep Apnea Syndromes
Treatment polysomnography, Sleepiz One+
Clinical Study IdentifierNCT04676191
SponsorSleepiz AG
Last Modified on21 March 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Sleep apnea or Sleep Apnea Syndromes?
Do you have any of these conditions: Sleep Apnea Syndromes or Sleep apnea?
Do you have any of these conditions: Sleep apnea or Sleep Apnea Syndromes?
Do you have any of these conditions: Sleep apnea or Sleep Apnea Syndromes?
Do you have any of these conditions: Sleep apnea or Sleep Apnea Syndromes?
Age >18years
Ability and consent to undergo electrophysiological routine assessment
Informed Consent as documented by signature
Patients diagnosed or suspected to suffer from sleep apnea or any other sleep related disorder or patients suffering from chronic cardiac, respiratory or neuromuscular disorders
Ambulatory or stationary patients of Klinik Lengg

Exclusion Criteria

Previous enrolment into the current study
Enrolment of the investigator, his/her family members, employees and other dependent persons
Cardiac pacemaker or another implanted electrical device
Women who are pregnant
Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note